Aldose reductase inhibitors: pharmacological data and therapeutic perspectives
- 31 December 1985
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 6, 328-330
- https://doi.org/10.1016/0165-6147(85)90152-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic ratsDiabetologia, 1983
- The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic ratsDiabetes, 1982
- Kinetics of an orally absorbed aldose reductase inhibitor, sorbinilClinical Pharmacology & Therapeutics, 1981
- Aldose reductase in diabetic cataractsJAMA, 1981
- Effect of an Aldose Reductase Inhibitor on Diabetic Peripheral NeuropathyArchives of Neurology, 1981
- Aldose reductase inhibition: Studies with alrestatinMetabolism, 1979
- CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic ratsMetabolism, 1979
- Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase InhibitorScience, 1973
- The Sorbitol Pathway: Enzyme Localization and Content in Normal and Diabetic Nerve and CordDiabetes, 1968
- Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in DiabetesScience, 1966